Coordinatore | UNIVERSITY OF PATRAS
Organization address
address: UNIVERSITY CAMPUS RIO PATRAS contact info |
Nazionalità Coordinatore | Greece [EL] |
Totale costo | 3˙586˙420 € |
EC contributo | 3˙199˙527 € |
Programma | FP7-REGPOT
Specific Programme "Capacities": Research potential of Convergence Regions |
Code Call | FP7-REGPOT-2011-1 |
Funding Scheme | CSA-SA |
Anno di inizio | 2012 |
Periodo (anno-mese-giorno) | 2012-01-01 - 2015-12-31 |
# | ||||
---|---|---|---|---|
1 |
UNIVERSITY OF PATRAS
Organization address
address: UNIVERSITY CAMPUS RIO PATRAS contact info |
EL (RIO PATRAS) | coordinator | 3˙199˙527.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'SEE-DRUG’s Major Aim is to strengthen and broaden the scientific reach and socio-economic impact of the University of Patras (UPAT) through the creation of a Regional Centre of Excellence for Structural Biology that emphasizes the characterization and development of bioactive molecules with therapeutic potential. SEE-DRUG takes advantage of UPAT’s pivotal strength and growth potential of Structural Biology and combines it with high-quality, multidisciplinary scientific expertise in Chemistry, Pharmacology, Biology & Bioinformatics. The SEE-DRUG project will enable: (a) the Protein Production group to efficiently produce and characterize protein drug-targets for structural analysis and drug development efforts, (b) the Structural Biology group to perform high-resolution structure determination, through time- and cost-effective NMR-based, cutting-edge techniques, and (c) the Pharmacology group to characterize lead therapeutic molecules in a comprehensive array of in vitro, ex vivo and in vivo systems. The long-term benefits of SEE-DRUG implementation will manifest on 3 levels: (a) the pooling of scientific expertise & the upgrading of infrastructure within UPAT, (b) the optimal integration of UPAT’s Structural Biology in ERA through the establishment of long-lasting partnerships, (c) the creation of a solid scientific platform that will become a pole for therapeutic biomolecule-oriented Structural Biology in Greece and in SouthEastern EU, and (d) the exchange of expertise (via twinning actions with 8 EU partnering organizations) and the building of networks with other scientists and technology end-users at a regional or local level, including the bio-pharmaceutical industry. Last, but not least, such a state-of-the-art Centre will create a number of positions for highly skilled scientists and thus enhance scientific and economic growth both at a local and at a regional level, which will hopefully be sustained for years to come.'
"Centre of Excellence in Genomics, Biotechnology and Quality of Animal Products in Sustainable Production Systems with consideration of Animal Welfare"
Read More